In this paper, several advances were implemented for glycoprofiling of prostate specific antigen (PSA), which can be applied for better prostate cancer (PCa) diagnostics in the future:
- application of Au nanoshells with a magnetic core (MP@silica@Au);
- use of surface plasmons of Au nanoshells with a magnetic core for spontaneous immobilization of zwitterionic molecules via diazonium salt grafting;
- a double anti-fouling strategy with the integration of zwitterionic molecules on Au surface and on MP@silica@Au particles was implemented to resist non-specific protein binding;
- application of anti-PSA antibody modified Au nanoshells with a magnetic core for the enrichment of PSA from a complex matrix of a human serum;
- direct incubation of anti-PSA modified MP@silica@Au with affinity bound PSA to the lectin modified electrode surface.
The electrochemical impedance spectroscopy (EIS) signal was enhanced 43 times by integrating Au nanoshells with a magnetic core compared to the biosensor without them. This proof-of-concept study shows that the biosensor could detect PSA down to 1.2 fmol/L and at the same time to glycoprofile such low PSA concentration using a lectin patterned biosensor device. The biosensor offers a recovery index of 108 % when the serum sample was spiked with a physiological concentration of PSA (3.5 ng mL-1).
Article:
T. Bertok, L. Lorencova, S. Hroncekova, V. Gajdosova, E. Jane, M. Hires, P. Kasak, O. Kaman, R. Sokol, V. Bella, A. Andicsova Eckstein, J. Mosnacek, A. Vikartovska, and J.Tkac, Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core, Biosensors and Bioelectronics, Volume 131, 15 April 2019, Pages 24-29.